Related Experiment Video
Updated: Feb 7, 2026

Determination of the Glycogen Content in Cyanobacteria
Published on: July 17, 2017
Cyanobacteria-derived peptide antibiotics discovered since 2000
Yun Xue1, Pengchao Zhao1, Chunshan Quan2
1College of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, 471023, China.
Abstract:
Members of cyanobacteria, including Moorea spp., Okeania spp., Lyngbya spp., Schizothrix spp., Leptolyngbya spp., Microcystis spp., Symploca spp., Hassallia sp., Anabaena spp., Planktothrix sp., Tychonema spp., Oscillatoria spp., Tolypothrix sp., Nostoc sp., and Hapalosiphon sp. produce an enormously diverse range of peptide antibiotics with huge potential as pharmaceutical drugs and biocontrol agents following screening of structural analogues and analysis of structure-activity relationships (SAR). The need for novel antibiotic lead compounds is urgent, and this review summarizes 78 cyanobacteria-derived compounds reported since 2000, including 32 depsipeptides, 18 cyclic lipopeptides, 13 linear lipopeptides, 14 cyclamides, and one typical cyclic peptide. The current and potential therapeutic applications of these peptides are discussed, including for SAR, antituberculotic, antifungal, antibacterial, antiviral, and antiparasitic (anti-plasmodial, antitrypanosomal and antileishmanial) activities.
Related Concept Videos
Antibiotic Selection
Peptide Bonds
Bacterial Phylum Cyanobacteria
Development of Antibiotic Resistance
Measurement: Derived Units
Higher Derivatives

